GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)

SHA:600771 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	231.34	116.67	259.97	246.4	145.15	393.67
Cash & Short-Term Investments	231.34	116.67	259.97	246.4	145.15	393.67
Cash Growth	-39.95%	-55.12%	5.51%	69.76%	-63.13%	65.18%
Accounts Receivable	514.81	439.13	830.73	1,033	1,460	1,863
Other Receivables	18.62	10.83	1.66	56.53	143.34	148.7
Receivables	533.43	449.96	832.39	1,089	1,603	2,011
Inventory	715.74	766.95	569.53	415.04	352.9	362.67
Other Current Assets	27.31	33.83	20.33	13.15	24.07	43.73
Total Current Assets	1,508	1,367	1,682	1,764	2,125	2,811
Property, Plant & Equipment	653.52	663.48	707.24	710.26	738.37	769.75
Long-Term Investments	14.79	16.57	25.89	32.89	53.89	54.07
Other Intangible Assets	94.98	96.09	93.75	98.54	96.13	100.3
Long-Term Deferred Tax Assets	96.73	95.93	91.69	73.69	61.29	36.87
Long-Term Deferred Charges	3.63	3.79	4.34	6.16	12.37	9.89
Other Long-Term Assets	32.74	32.61	23.28	15.32	15.37	15.71
Total Assets	2,404	2,276	2,628	2,701	3,102	3,798
Accounts Payable	104.83	60.27	56.41	263.87	489.08	785.34
Accrued Expenses	473.4	373.13	508.35	419.04	54.25	57.95
Short-Term Debt	33.67	19.95	56.06	165	245.86	299.8
Current Portion of Long-Term Debt	-	-	189.86	62.2	12	10
Current Portion of Leases	11.25	8.19	6.33	1.93	-	-
Current Income Taxes Payable	36.51	2.17	0.71	-	1.42	1.37
Current Unearned Revenue	35.45	50.83	69.02	38.78	20.25	24.64
Other Current Liabilities	3.51	119.16	156.82	106.49	50.62	92.97
Total Current Liabilities	698.62	633.7	1,044	1,057	873.49	1,272
Long-Term Debt	-	-	-	197.6	70	26
Long-Term Leases	31.58	33.79	39.11	6.2	-	-
Long-Term Unearned Revenue	15.27	15.27	15.1	13.63	15.35	17.82
Long-Term Deferred Tax Liabilities	2.4	2.4	13.51	2.7	2.81	2.43
Other Long-Term Liabilities	-	-	9.27	-	-	10
Total Liabilities	747.87	685.17	1,121	1,277	961.65	1,328
Common Stock	489.49	489.49	489.49	489.49	492	492
Additional Paid-In Capital	1,588	1,588	1,588	1,588	1,637	1,637
Retained Earnings	-441.02	-504.61	-579.06	-669.14	17.17	333.41
Treasury Stock	-	-	-	-	-51.22	-51.22
Comprehensive Income & Other	-3.29	-3.29	-2.52	5.55	4.53	1.01
Total Common Equity	1,633	1,570	1,496	1,414	2,099	2,412
Minority Interest	22.95	20.9	11.74	9.25	41.42	57.52
Shareholders' Equity	1,656	1,591	1,508	1,423	2,141	2,470
Total Liabilities & Equity	2,404	2,276	2,628	2,701	3,102	3,798
Total Debt	76.5	61.94	291.36	432.93	327.86	335.8
Net Cash (Debt)	154.84	54.74	-31.39	-186.54	-182.71	57.87
Net Cash Growth	62.23%	-	-	-	-	-10.84%
Net Cash Per Share	0.31	0.11	-0.06	-0.38	-0.37	0.13
Filing Date Shares Outstanding	489.49	489.49	489.49	489.49	489.49	489.49
Total Common Shares Outstanding	489.49	489.49	489.49	489.49	489.49	489.49
Working Capital	809.2	733.71	638.67	706.65	1,252	1,539
Book Value Per Share	3.34	3.21	3.06	2.89	4.29	4.93
Tangible Book Value	1,538	1,474	1,402	1,316	2,003	2,312
Tangible Book Value Per Share	3.14	3.01	2.86	2.69	4.09	4.72
Buildings	-	724.01	728	740.85	744.18	747.38
Machinery	-	165.14	161.58	162.29	162.16	157.73
Construction In Progress	-	-	-	-	-	1.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.